ANROVSGTBP• 6 Months (Normalized)
ANRO vs GTBP (Alto Neuroscience Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Apr 2 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANRO Performance $27.5
+%
Alto Neuroscience Inc.
Normalized Baseline0.00%
GTBP Performance $6.88
+1427.78%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-1427.78 pts
GTBP outperforming by 1427.78 percentage points
ANROGTBP
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANRO GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | ANRO Price | ANRO Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $- | $6.88 | +1427.78% | - | |
| Sep 28, 2026 | $- | $6.80 | +1411.11% | - | |
| Sep 25, 2026 | $- | $6.89 | +1431.11% | - | |
| Sep 24, 2026 | $- | $6.83 | +1417.78% | - | |
| Sep 23, 2026 | $27.50 | +26.85% | $7.10 | +1477.78% | -1450.93% |
| Sep 22, 2026 | $30.78 | +41.97% | $- | - | |
| Sep 21, 2026 | $30.63 | +41.28% | $7.18 | +1495.56% | -1454.28% |
| Sep 18, 2026 | $30.27 | +39.62% | $7.16 | +1491.11% | -1451.49% |
| Sep 17, 2026 | $30.98 | +42.90% | $7.49 | +1564.44% | -1521.54% |
| Sep 16, 2026 | $30.00 | +38.38% | $7.81 | +1635.56% | -1597.18% |
| Sep 15, 2026 | $30.25 | +39.53% | $9.00 | +1900.00% | -1860.47% |
| Sep 14, 2026 | $31.68 | +46.13% | $11.63 | +2484.44% | -2438.31% |
| Sep 11, 2026 | $32.00 | +47.60% | $8.61 | +1813.33% | -1765.73% |
| Sep 10, 2026 | $31.68 | +46.13% | $6.18 | +1273.33% | -1227.20% |
| Sep 09, 2026 | $34.07 | +57.15% | $5.98 | +1228.89% | -1171.74% |
Page 1 of 9